Analyzing Aviragen Therapeutics Inc’s (NASDAQ:AVIR) track record of past performance is a valuable exercise for investors. It enables us to reflect on whether or not the company has met expectations, ...

If you are looking to invest in Aviragen Therapeutics Inc’s (NASDAQ:AVIR), or currently own the stock, then you need to understand its beta in order to understand how it can affect the risk of your ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Innovative vaccines for intranasal spray delivery or oral administration combine high efficacy with easy application. For the first time study data are available on the vaccine in its trivalent ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Atea Pharmaceuticals, Inc. (AVIR) been one of those stocks ...

VIENNA--(BUSINESS WIRE)--Studies performed in three animal models confirmed the safety and intensive immunogenicity of a new type of intranasal H5N1 influenza vaccine, according to the latest ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...